Like all industries, the pharma industry has been disrupted by the Covid-19 pandemic. The generics industry has been impacted particularly by supply chain problems and huge surges in demand for existing medicines.
Accord’s head of scientific affairs Dr Anthony Grosso explains how the industry has worked to overcome these challenges and respond to the needs of patients, as well as become more prepared for future healthcare emergencies.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Read the full story here.
